Table 4.

Patient clinical end points.

	Group A (n = 132)	Group B (n = 45)	p
Follow-up time, months	39 (31.5–45)	35 (13.5–42)	0.015
In-hospital mortality	1 (0.76%)	3 (6.67%)	0.085
Midterm mortality	14 (10.61%)	20 (44.44%)	<0.001
Take medication as prescribed	106 (80.30%)	31 (68.89%)	0.22
Reoperation	16 (12.12%)	7 (15.56%)	0.519
Reoperation time, months	10.56 ± 10.03	17.00 ± 17.70	0.276
Total complications	36 (27.27%)	17 (37.78%)	0.155
Dindo-Clavien classification
Mild complication	64 (48.48%)	16 (31.11%)	0.166
Sever complication	18 (13.64%)	5 (11.11%)	0.800
Fatal complication	14 (10.61%)	20 (44.44%)	<0.001
Surgical complications	19 (%)	10 (22.22%)	0.197
Acute organ injury	10	4
Postoperative infection	1	2
Others	8	4
Graft-related complications	17 (12.88%)	10 (22.22%)	0.116
Type I leakage	2	0
Type II leakage	5	4
Implant infection	1	0
In-stent restenosis	9	6
Length of stay, days	11.10 (8.80–14.1)	13.00 (8.85–17.60)	0.112